Elicera – IPO

Elicera – IPO

Elicera - IPO 07 JuniJun 2021 12:00 - 12:30Online Event

Meet and ask questions directly to Elicera Therapeutics CEO, Jamal El-Mosleh.

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Elicera Therapeutics is going public in Sweden and the last day of the subscription period is 8th of june.



Elicera - IPO 07 JuniJun 2021 12:00 - 12:30
Elicera - IPO Online Event